Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.

Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators.

N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104.

PMID:
30184451
2.

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Gressin R, Daguindau N, Tempescul A, Moreau A, Carras S, Tchernonog E, Schmitt A, Houot R, Dartigeas C, Pignon JM, Corm S, Banos A, Mounier C, Dupuis J, Macro M, Fleury J, Jardin F, Sarkozy C, Damaj G, Feugier P, Fornecker LM, Chabrot C, Dorvaux V, Bouadallah K, Amorin S, Garidi R, Voillat L, Joly B, Celigny PS, Morineau N, Moles MP, Zerazhi H, Fontan J, Arkam Y, Alexis M, Delwail V, Vilque JP, Ysebaert L, Le Gouill S, Callanan MB; Lymphoma Study Association.

Haematologica. 2019 Jan;104(1):138-146. doi: 10.3324/haematol.2018.191429. Epub 2018 Aug 31.

3.

[Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].

Deroux A, Sirodot M, Daguindau N, Barro C, Coppo P, Bouillet L.

Rev Med Interne. 2016 Jan;37(1):13-8. doi: 10.1016/j.revmed.2015.05.003. Epub 2015 Jun 9. French.

PMID:
26065327
4.

The translocation t(4;14) can be present only in minor subclones in multiple myeloma.

Hébraud B, Caillot D, Corre J, Marit G, Hulin C, Leleu X, Lodé L, Wetterwald M, Dib M, Rodon P, Voillat L, Royer B, Voog E, Fitoussi O, Stoppa AM, Garderet L, Kolb B, Maigre M, Boullanger N, Allangba O, Karlin L, Daguindau N, Legros L, Sohn C, Joubert MV, Lenain P, Facon T, Attal M, Moreau P, Avet-Loiseau H.

Clin Cancer Res. 2013 Sep 1;19(17):4634-7. doi: 10.1158/1078-0432.CCR-12-3866. Epub 2013 Jul 15.

5.

Immune constitution monitoring after PBMC transplantation in complete DiGeorge syndrome: an eight-year follow-up.

Daguindau N, Decot V, Nzietchueng R, Ferrand C, Picard C, Latger-Cannard V, Gregoire MJ, Beri M, Salmon A, Stoltz JF, Bordigoni P, Bensoussan D.

Clin Immunol. 2008 Aug;128(2):164-71. doi: 10.1016/j.clim.2008.03.524. Epub 2008 Jun 2.

PMID:
18515186
6.

[Criteria of the eligibility of patients for treatment with intravenous normal human immunoglobulin].

Feugier P, Tomowiak C, Daguindau N, Perrot A.

Rev Med Interne. 2007 Jun;28 Spec No 2:7-9. French. No abstract available.

PMID:
17893961
7.

[Multiple myeloma and intravenous immunoglobulins].

Feugier P, Tomowiak C, Daguindau N, Perrot A.

Rev Med Interne. 2007 Jun;28 Spec No 2:5-6. Review. French. No abstract available.

PMID:
17893960
8.

[Chronic lymphoid leukemia and intravenous immunoglobulins].

Feugier P, Tomowiak C, Daguindau N, Perrot A.

Rev Med Interne. 2007 Jun;28 Spec No 2:2-4. Review. French. No abstract available.

PMID:
17893959
9.

[Secondary deficiencies of humoral immunity in hematology: what management?].

Feugier P, Tomowiak C, Daguindau N, Perrot A.

Rev Med Interne. 2007 Jun;28 Spec No 2:1. French. No abstract available.

PMID:
17893958

Supplemental Content

Loading ...
Support Center